Profile | GDS4284 / 233359_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 672.198 | 68 |
GSM687648 | Patient 402 control | 601.191 | 66 |
GSM687653 | Patient 403 control | 732.573 | 70 |
GSM687658 | Patient 404 control | 835.051 | 71 |
GSM687663 | Patient 411 control | 874.73 | 72 |
GSM687668 | Patient 422 control | 920.364 | 73 |
GSM687673 | Patient 424 control | 717.26 | 69 |
GSM687678 | Patient 425 control | 1374.4 | 78 |
GSM687683 | Patient 427 control | 887.937 | 72 |
GSM687688 | Patient 428 control | 980.55 | 74 |
GSM687695 | Patient 441 control | 741.441 | 70 |
GSM687699 | Patient 443 control | 881.645 | 72 |
GSM687704 | Patient 444 control | 769.783 | 70 |
GSM687707 | Patient 448 control | 724.106 | 69 |
GSM687712 | Patient 449 control | 865.995 | 72 |
GSM687719 | Patient 450 control | 727.786 | 68 |
GSM687724 | Patient 451 control | 934.812 | 73 |
GSM687728 | Patient 452 control | 1114.16 | 76 |
GSM687646 | Patient 401 treated 24h | 952.251 | 73 |
GSM687649 | Patient 402 treated 24h | 707.214 | 69 |
GSM687665 | Patient 411 treated 24h | 781.007 | 70 |
GSM687651 | Patient 402 treated 4 weeks | 512.956 | 63 |
GSM687667 | Patient 411 treated 4 weeks | 993.709 | 73 |
GSM687670 | Patient 422 treated 24h | 875.035 | 71 |
GSM687671 | Patient 422 treated 4 weeks | 870.515 | 72 |
GSM687654 | Patient 403 treated 24h | 771.81 | 70 |
GSM687675 | Patient 424 treated 24h | 665.33 | 67 |
GSM687685 | Patient 427 treated 24h | 876.052 | 72 |
GSM687656 | Patient 403 treated 4 weeks | 717.235 | 69 |
GSM687677 | Patient 424 treated 4 weeks | 771.098 | 70 |
GSM687687 | Patient 427 treated 4 weeks | 730.452 | 69 |
GSM687692 | Patient 428 treated 4h | 918.895 | 73 |
GSM687716 | Patient 449 treated 4h | 865.076 | 72 |
GSM687722 | Patient 450 treated 4h | 855.108 | 71 |
GSM687680 | Patient 425 treated 24h | 1215.54 | 77 |
GSM687690 | Patient 428 treated 24h | 933.426 | 73 |
GSM687700 | Patient 443 treated 24h | 1032.39 | 74 |
GSM687705 | Patient 444 treated 24h | 667.648 | 68 |
GSM687714 | Patient 449 treated 24h | 713.467 | 69 |
GSM687721 | Patient 450 treated 24h | 1099.31 | 76 |
GSM687682 | Patient 425 treated 4 weeks | 1207.64 | 77 |
GSM687694 | Patient 428 treated 4 weeks | 690.053 | 68 |
GSM687702 | Patient 443 treated 4 weeks | 809.993 | 70 |
GSM687718 | Patient 449 treated 4 weeks | 664.352 | 68 |
GSM687723 | Patient 450 treated 4 weeks | 1082.99 | 75 |
GSM687661 | Patient 404 treated 4h | 890.883 | 72 |
GSM687710 | Patient 448 treated 4h | 686.036 | 69 |
GSM687726 | Patient 451 treated 4h | 1160.94 | 76 |
GSM687730 | Patient 452 treated 4h | 517.568 | 57 |
GSM687660 | Patient 404 treated 24h | 567.298 | 66 |
GSM687697 | Patient 441 treated 24h | 967.528 | 74 |
GSM687709 | Patient 448 treated 24h | 553.922 | 65 |
GSM687725 | Patient 451 treated 24h | 893.541 | 72 |
GSM687729 | Patient 452 treated 24h | 630.859 | 68 |
GSM687727 | Patient 451 treated 4 weeks | 1268.86 | 77 |
GSM687731 | Patient 452 treated 4 weeks | 974.338 | 73 |